PMI (NYSEAMERICAN:PMI) Given “Neutral” Rating at HC Wainwright

PMI (NYSEAMERICAN:PMI)‘s stock had its “neutral” rating reaffirmed by HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports.

Separately, Zacks Research upgraded shares of PMI to a “hold” rating in a research report on Tuesday, May 19th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

PMI Stock Up 60.3%

NYSEAMERICAN PMI opened at $0.27 on Wednesday. The company’s 50-day simple moving average is $0.61. PMI has a 52 week low of $0.11 and a 52 week high of $13.68. The company has a quick ratio of 0.16, a current ratio of 0.75 and a debt-to-equity ratio of 0.01.

PMI (NYSEAMERICAN:PMI) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.10) earnings per share (EPS) for the quarter. The company had revenue of $1.15 million for the quarter. On average, equities analysts predict that PMI will post -0.17 EPS for the current fiscal year.

PMI Company Profile

Picard Medical Inc is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc is based in TUCSON, Ariz.